NASDAQ:IVTY - Invuity Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$7.40 +0.05 (+0.68 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$7.35
Today's Range$7.35 - $7.40
52-Week Range$2.35 - $9.55
Volume566,500 shs
Average Volume322,451 shs
Market Capitalization$178.15 million
P/E Ratio-3.34
Dividend YieldN/A
Beta0.14
Invuity logoInvuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities. It offers various illuminated surgical devices, including Eikon LT illuminated retractor system for breast/oncoplastic/gynecology/EP/plastic/endocrine surgeries; Eiberg illuminated retractor systems for orthopedic surgeries; PhotonBlade, a recision illuminator for breast/plastics/EP/orthopedics surgeries; PhotonSaber Y, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general/gynecology/plastic surgeries; and PhotonSaber F, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Breiten illuminated retractor systems for spine/orthopedic surgeries; Photonguide XT system, a drop-in intracavity illuminator for spine surgeries; Eika illuminated retractor systems for endocrine/spine/orthopedic surgeries; and PhotonVue, a system used in conjunction with IC Indocyanine for identifying and verifying blood flow in tissue, as well as is used in breast/plastic/colorectal surgeries. It sells its devices through direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.

Receive IVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for IVTY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:IVTY
CUSIPN/A
Phone415-655-2100

Debt

Debt-to-Equity Ratio10.57
Current Ratio2.13
Quick Ratio1.69

Price-To-Earnings

Trailing P/E Ratio-3.34
Forward P/E Ratio-5.25
P/E GrowthN/A

Sales & Book Value

Annual Sales$39.62 million
Price / Sales4.50
Cash FlowN/A
Price / CashN/A
Book Value($0.05) per share
Price / Book-148.00

Profitability

EPS (Most Recent Fiscal Year)($2.20)
Net Income$-39,910,000.00
Net Margins-89.29%
Return on Equity-837.22%
Return on Assets-71.82%

Miscellaneous

Employees161
Outstanding Shares24,070,000
Market Cap$178.15 million

Invuity (NASDAQ:IVTY) Frequently Asked Questions

What is Invuity's stock symbol?

Invuity trades on the NASDAQ under the ticker symbol "IVTY."

How were Invuity's earnings last quarter?

Invuity Inc (NASDAQ:IVTY) announced its quarterly earnings results on Thursday, August, 2nd. The medical instruments supplier reported ($0.37) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.10. The medical instruments supplier had revenue of $10.50 million for the quarter, compared to analyst estimates of $10.73 million. Invuity had a negative net margin of 89.29% and a negative return on equity of 837.22%. View Invuity's Earnings History.

When is Invuity's next earnings date?

Invuity is scheduled to release their next quarterly earnings announcement on Tuesday, November, 6th 2018. View Earnings Estimates for Invuity.

What price target have analysts set for IVTY?

5 brokers have issued twelve-month price targets for Invuity's shares. Their predictions range from $5.00 to $12.00. On average, they anticipate Invuity's share price to reach $7.6667 in the next year. This suggests a possible upside of 3.6% from the stock's current price. View Analyst Price Targets for Invuity.

What is the consensus analysts' recommendation for Invuity?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invuity in the last year. There are currently 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Invuity.

What are Wall Street analysts saying about Invuity stock?

Here are some recent quotes from research analysts about Invuity stock:
  • 1. According to Zacks Investment Research, "Invuity, Inc. is a medical technology company. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System and Waveguide XT System. The Company sells its devices through its direct sales representatives and original equipment manufacturers of surgical systems. Invuity, Inc. is based in San Francisco, California. " (7/5/2018)
  • 2. Northland Securities analysts commented, "We would be remiss in not expressing our disappointment, and are lowering our PT to $6." (2/14/2018)

Who are some of Invuity's key competitors?

Who are Invuity's key executives?

Invuity's management team includes the folowing people:
  • Mr. Scott D. Flora, Interim Pres, CEO & Director (Age 62)
  • Mr. Philip M. Sawyer, CEO, Pres & Director (Age 53)
  • Mr. James H. MacKaness, Chief Financial Officer (Age 54)
  • Mr. Douglas W. Heigel, Sr. VP of Operations (Age 57)
  • Ms. Marcia Fish, Chief HR Officer (Age 54)

When did Invuity IPO?

(IVTY) raised $48 million in an initial public offering on the week of June 15th 2015. The company issued 4,000,000 shares at $12.00 per share. Piper Jaffray, Leerink Partners and Stifel acted as the underwriters for the IPO and William Blair was co-manager.

Has Invuity been receiving favorable news coverage?

Media stories about IVTY stock have trended somewhat positive this week, according to Accern. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Invuity earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave news stories about the medical instruments supplier an impact score of 46.57 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View Recent Headlines for Invuity.

Who are Invuity's major shareholders?

Invuity's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Cannell Capital LLC (6.22%), Millennium Management LLC (2.78%), Perkins Capital Management Inc. (1.30%), Royce & Associates LP (0.69%), Kornitzer Capital Management Inc. KS (0.43%) and BlackRock Inc. (0.23%). Company insiders that own Invuity stock include Alex Vayser, Andrew Sale, Eric W Roberts, Gregory T Lucier, James E Flynn, James H Mackaness, Marcia Fish, Philip M Sawyer, Reza Zadno, Robert Gerberich and Scott D Flora. View Institutional Ownership Trends for Invuity.

Which institutional investors are buying Invuity stock?

IVTY stock was bought by a variety of institutional investors in the last quarter, including Cannell Capital LLC, Millennium Management LLC, Perkins Capital Management Inc., Fondren Management LP, Royce & Associates LP, Kornitzer Capital Management Inc. KS, Spark Investment Management LLC and BlackRock Inc.. Company insiders that have bought Invuity stock in the last two years include Andrew Sale, Eric W Roberts, Gregory T Lucier, James H Mackaness, Marcia Fish and Scott D Flora. View Insider Buying and Selling for Invuity.

How do I buy shares of Invuity?

Shares of IVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Invuity's stock price today?

One share of IVTY stock can currently be purchased for approximately $7.40.

How big of a company is Invuity?

Invuity has a market capitalization of $178.15 million and generates $39.62 million in revenue each year. The medical instruments supplier earns $-39,910,000.00 in net income (profit) each year or ($2.20) on an earnings per share basis. Invuity employs 161 workers across the globe.

How can I contact Invuity?

Invuity's mailing address is 444 DE HARO STREET, San Francisco CA, 94107. The medical instruments supplier can be reached via phone at 415-655-2100 or via email at [email protected]


MarketBeat Community Rating for Invuity (NASDAQ IVTY)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  181 (Vote Outperform)
Underperform Votes:  169 (Vote Underperform)
Total Votes:  350
MarketBeat's community ratings are surveys of what our community members think about Invuity and other stocks. Vote "Outperform" if you believe IVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel